Edition:
United States

PerkinElmer Inc (PKI)

PKI on New York Consolidated

71.64USD
23 Oct 2017
Change (% chg)

$-0.09 (-0.13%)
Prev Close
$71.73
Open
$71.73
Day's High
$71.91
Day's Low
$71.39
Volume
525,972
Avg. Vol
625,984
52-wk High
$72.11
52-wk Low
$45.35

Select another date:

Fri, Sep 15 2017

BRIEF-PerkinElmer ‍announced upcoming retirement of Andy Wilson CFO

* PerkinElmer Inc - ‍Announced upcoming retirement of Andy Wilson, senior vice president and chief financial officer​

BRIEF-PerkinElmer launches QSight210 MD system for clinical laboratories

* PerkinElmer Inc - launches QSight210 MD system for clinical laboratories Source text for Eikon: Further company coverage:

BRIEF-PerkinElmer enters into 364-day unsecured term loan facility

* PerkinElmer Inc - ‍on August 11, entered into a 364-day unsecured term loan facility in principal amount of $200 million - SEC filing​

REFILE-BRIEF-PerkinElmer launches clinical whole genome sequencing services

* PerkinElmer launches clinical whole genome sequencing services

PerkinElmer profit meets Street view, boosts 2017 forecast range

Scientific instruments maker PerkinElmer Inc on Thursday posted a second-quarter profit that matched expectations and boosted its full-year earnings forecast range with a new midpoint slightly ahead of Wall Street estimates.

UPDATE 1-PerkinElmer profit meets Street view, boosts 2017 forecast range

Aug 3 Scientific instruments maker PerkinElmer Inc on Thursday posted a second-quarter profit that matched expectations and boosted its full-year earnings forecast range with a new midpoint slightly ahead of Wall Street estimates.

BRIEF-PerkinElmer reports Q2 GAAP EPS from continuing operations $0.57

* Q2 GAAP earnings per share from continuing operations $0.57; Q2 adjusted earnings per share $0.67; Q2 GAAP revenue $547.0 million versus $536.2 million

PerkinElmer profit meets Street view, raises 2017 forecast

Aug 3 Scientific instruments maker PerkinElmer Inc on Thursday reported second quarter profit that matched expectations and boosted its full-year earnings forecast range with a new midpoint slightly ahead of Wall Street estimates.

PerkinElmer to buy Germany's Euroimmun for about $1.3 billion

Scientific instruments maker PerkinElmer Inc said on Monday it would buy Germany's Euroimmun Medical Laboratory Diagnostics AG for about $1.3 billion in cash to expand its reach into autoimmune and allergy diagnostic markets.

UPDATE 1-PerkinElmer to buy Germany's Euroimmun for about $1.3 bln

June 19 Scientific instruments maker PerkinElmer Inc said on Monday it would buy Germany's Euroimmun Medical Laboratory Diagnostics AG for about $1.3 billion in cash to expand its reach into autoimmune and allergy diagnostic markets.

Select another date: